Skip to content

Abnormal Cardiomyocyte Mitochondrial Morphology C4531188

Published: July 22, 2026Updated: August 20, 2026

A condition affecting the shape of energy-producing structures in heart cells, which may signal underlying cardiac dysfunction. Management focuses on identifying and treating the root cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest Discomfort

Pressure, squeezing, or pain in the chest that may radiate to the arm, jaw, or back.

Seek immediate medical attention if chest pain is severe, radiating, or accompanied by shortness of breath, sweating, or nausea.

!

Cardiac Arrhythmia

Irregular heart rhythm that may manifest as tachycardia, bradycardia, or irregular beats.

Seek immediate care if experiencing fainting, severe dizziness, or chest pain with irregular heartbeat.

Fatigue

(constitutional)

Persistent feeling of tiredness and lack of energy that is not relieved by rest.

Frequency: 70-80% of patients

Exercise Intolerance

(cardiovascular)

Inability to perform physical activity at expected levels due to rapid onset of exhaustion.

Frequency: 65-75% of patients

Shortness of Breath

(respiratory)

Difficulty breathing or feeling breathless, especially during physical exertion or when lying flat.

Frequency: 50-60% of patients

Palpitations

(cardiovascular)

Awareness of rapid, fluttering, or irregular heartbeat.

Frequency: 40-50% of patients

Dizziness

(neurologic)

Feeling of lightheadedness, unsteadiness, or faintness, particularly when standing up quickly.

Frequency: 15-20% of patients

Peripheral Edema

(cardiovascular)

Swelling in the legs, ankles, or feet due to fluid retention from reduced cardiac function.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Coenzyme Q10 supplementation

CoQ10 supports mitochondrial electron transport chain function and ATP production, potentially improving cardiomyocyte energy metabolism in mitochondrial abnormalities.

medication
2

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Mitochondrial support diet

Ketogenic or low-glycemic diets may reduce oxidative stress and support mitochondrial function; emphasis on healthy fats and complex carbohydrates.

dietary

Additional treatment options

L-carnitine supplementation

Carnitine facilitates fatty acid transport into mitochondria for energy production and may improve cardiac energy metabolism in fatty acid oxidation defects.

complementary

Exercise stress testing with metabolic gas analysis

Cardiopulmonary exercise testing evaluates oxygen consumption, ventilatory efficiency, and anaerobic threshold to assess mitochondrial reserve and functional capacity.

monitoring

Energy conservation techniques

Pacing activities and incorporating rest periods prevents energy depletion, reduces fatigue, and optimizes daily functioning within cardiac capacity limits.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Cardiomyocyte Mitochondrial Morphology C4531188?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421.

guideline2022View source →
2

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.

guideline2021View source →
3

Dorn GW 2nd, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 2015;29(19):1981-1991.

review2015View source →
4

Gottlieb RA, Gustafsson AB. Mitochondrial dynamics in the heart: implications for disease. Nat Rev Cardiol. 2023;20(4):267-283.

review2023View source →
5

Anderson L, Dodd KW, Humbles J, et al. Exercise training in heart failure: a position statement from the British Society for Heart Failure. Br J Cardiol. 2020;27(3):27.

position_statement2020View source →
6

Marin-Garcia J, Akhmedov AT. Mitochondrial dynamics and cell death in heart failure. Heart Fail Rev. 2016;21(2):123-136.

review2016View source →
7

Zhang Y, Wang Y, Liu X, et al. Mitochondrial dysfunction in heart failure: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:783102.

meta_analysis2021View source →
8

Sabbah HN, Gupta RC, Kohli S, et al. Chronic therapy with elamipretide (SS-31) in patients with stable heart failure: results from the ReDUX trial. JACC Heart Fail. 2020;8(4):291-300.

clinical_trial2020View source →
9

Chalkias A, Xanthos T. Mitochondrial pathology in cardiac dysfunction. J Cell Mol Med. 2022;26(9):2482-2495.

review2022View source →
10

Tschöpe C, Khadour L, Kahlert P, et al. Mitochondrial cardiology: consensus statement on classifications and definitions. Eur J Heart Fail. 2021;23(11):1833-1845.

consensus2021View source →

Medication Comparisons

Compare medications used to treat Abnormal Cardiomyocyte Mitochondrial Morphology C4531188. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy